AFAP1 and breast cancer: There is a growing body of evidence suggesting the upregulation of AFAP1‐AS1, an antisense lncRNA, in various cancer types, including breast cancer,9 cervical cancer,10 pancreatic cancer,11 lung cancer,12 esophageal squamous cell carcinoma.13